A Prospective Phase II Clinical Trial Evaluating the Efficacy and Safety of Adebrelimab in Combination With Trastuzumab Rezetecan for Patients With Stage III Unresectable HER2-Positive NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
- Status
- RECRUITING
- Phase
- PHASE3
Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Multimodal Ablation Combined With Perioperative Tislelizumab and Chemotherapy for Resectable II-IIIB NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SKB264 in Combination With SKB118 for Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Phase Ib Study of Tislelizumab Plus SYS6010 in Immunotherapy-Pretreated Locally Advanced or Metastatic NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Comparative ¹⁸F-FDG and ⁶⁸Ga-MY6349 PET/CT Imaging for Assessing TROP2 ADC Therapeutic Efficacy in EGFR-TKI Resistant Advanced NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
An Open-label, Fixed-sequence Phase I Clinical Trial to Evaluate the Effect of HS-10504 on the Pharmacokinetics of Midazolam in Patients With Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
SKB264 Plus Glecirasib in Advanced KRAS G12C-Mutant NSCLC: A Phase II Study
- Status
- RECRUITING
- Phase
- PHASE2
The Efficacy and Safety of Trastuzumab Deruxtecan in Advanced or Metastatic NSCLC With HER2 Over Expression
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
RGL-270 + ICI in Advanced NSCLC
- Status
- RECRUITING
- Phase
- NA
A Prospective, Multicenter, Randomized Controlled Study on the Efficacy and Safety of Low-dose Carboplatin Combined With Nab-Paclitaxel and Delayed Administration of Serplulimab as First-line Treatment for Advanced Squamous Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Efficacy and Safety of Induction Benmelstobart Plus Anlotinib and Chemotherapy Followed by Concurrent Chemoradiotherapy and Benmelstobart Maintenance Versus Concurrent Chemoradiotherapy Followed by Benmelstobart Maintenance in Patients With Unresectable Stage III NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
Firmonertinib in Perioperative Treatment of Resectable Stage II-IIIB EGFR-mutated Lung Adenocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Sub-lobectomy vs Lobectomy in IIA-IIIB NSCLC After Neoadjuvant IO+Chemo
- Status
- RECRUITING
- Phase
- NA
Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Imaging-based PRediction of Eligibility for ChemoImmunotherapy in reSEctable NSCLC, iPRECISE
- Status
- RECRUITING
- Phase
- N/A